Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2024-06-28 00:00:00 ET · period of report 2024-06-27 · accession 0001104659-24-076298 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-28 | 2024-06-27 | MBIO | Fortress Biotech, Inc. | 10% | A - Grant | $0.00 | +575.2K | 2.50M | +30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.0001 | 2024-06-27 | A | A | 575,191 | $0.00 | 2,502,991 | D | — | — | (F1) The Issuer is required to grant to the Reporting Person an equity fee in shares of the Issuer's Common Stock equal to 2.5% of the gross amount of any debt or equity financing consummated by the Issuer. 575,191 shares were granted by the Issuer to the Reporting Person following the closing of equity financings. |